Patents by Inventor Michael Koval

Michael Koval has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10919934
    Abstract: This disclosure relates to compositions for use in managing respiratory distress and related disorders. In certain embodiments, the disclosure relates to methods of treating or preventing respiratory distress comprising administering an effective amount of a pharmaceutical composition comprising peptides or agents disclosed herein to a subject in need thereof. In certain embodiments, the peptides or agents decrease the concentration of claudin-5 in cells and tissues of the lungs.
    Type: Grant
    Filed: July 7, 2020
    Date of Patent: February 16, 2021
    Assignee: Emory University
    Inventors: Michael Koval, Barbara Schlingmann
  • Patent number: 10817620
    Abstract: Methods, systems, and apparatus, including computer programs encoded on computer storage media, for securing sensitive user data. One of the methods includes receiving a request for user input; providing the request to a remote location; receiving, at a user device, code executable by display hardware to render a user interface configured to receive the user input; capturing information identifying the particular display device locations to which the user provided input on the rendered user interface; and providing the information to the remote location that maps the captured information to user interface information to determine the user input.
    Type: Grant
    Filed: March 20, 2019
    Date of Patent: October 27, 2020
    Assignee: MagicCube, Inc.
    Inventors: Jason Wu, Peter Crosthwaite, Michael Koval, Hesham Shawki, Nancy Zayed, Shin'ichiro Matsuo, Xi Zhou
  • Publication number: 20200331965
    Abstract: This disclosure relates to compositions for use in managing respiratory distress and related disorders. In certain embodiments, the disclosure relates to methods of treating or preventing respiratory distress comprising administering an effective amount of a pharmaceutical composition comprising peptides or agents disclosed herein to a subject in need thereof. In certain embodiments, the peptides or agents decrease the concentration of claudin-5 in cells and tissues of the lungs.
    Type: Application
    Filed: July 7, 2020
    Publication date: October 22, 2020
    Inventors: Michael Koval, Barbara Schlingmann
  • Patent number: 10738079
    Abstract: This disclosure relates to compositions for use in managing respiratory distress and related disorders. In certain embodiments, the disclosure relates to methods of treating or preventing respiratory distress comprising administering an effective amount of a pharmaceutical composition comprising peptides or agents disclosed herein to a subject in need thereof. In certain embodiments, the peptides or agents decrease the concentration of claudin-5 in cells and tissues of the lungs.
    Type: Grant
    Filed: April 13, 2018
    Date of Patent: August 11, 2020
    Assignee: Emory University
    Inventors: Michael Koval, Barbara Schlingmann
  • Publication number: 20200065515
    Abstract: Methods, systems, and apparatus, including computer programs encoded on computer storage media, for securing sensitive user data. One of the methods includes receiving a request for user input; providing the request to a remote location; receiving, at a user device, code executable by display hardware to render a user interface configured to receive the user input; capturing information identifying the particular display device locations to which the user provided input on the rendered user interface; and providing the information to the remote location that maps the captured information to user interface information to determine the user input.
    Type: Application
    Filed: March 20, 2019
    Publication date: February 27, 2020
    Inventors: Jason Wu, Peter Crosthwaite, Michael Koval, Hesham Shawki, Nancy Zayed, Shin'ichiro Matsuo
  • Publication number: 20180298057
    Abstract: This disclosure relates to compositions for use in managing respiratory distress and related disorders. In certain embodiments, the disclosure relates to methods of treating or preventing respiratory distress comprising administering an effective amount of a pharmaceutical composition comprising peptides or agents disclosed herein to a subject in need thereof. In certain embodiments, the peptides or agents decrease the concentration of claudin-5 in cells and tissues of the lungs.
    Type: Application
    Filed: April 13, 2018
    Publication date: October 18, 2018
    Inventors: Michael Koval, Barbara Schlingmann